|
|
Blood, 1 November 2006, Vol. 108, No. 9, pp. 3121-3127.
Prepublished online as a Blood First Edition Paper on July 13, 2006; DOI 10.1182/blood-2006-03-006809.
Previous Article | Next Article 
Submitted March 2, 2006
Accepted June 26, 2006
Strong selection of virus-specific cytotoxic CD4+ T cell clones during primary human cytomegalovirus infection
Ester M van Leeuwen*, Ester B Remmerswaal, Mirjam H Heemskerk, Ineke J ten Berge, and Rene A van Lier
Department of Experimental Immunology, Dept. of Internal Medicine,Academic Medical Center, Amsterdam
Dept. of Hematology, Leiden University Medical Center, Leiden, The Netherlands
Department of Internal Medicine, Division of Nephrology, Academic Medical Center, Amsterdam
Department of Experimental Immunology, Academic Medical Center, Amsterdam
* Corresponding author; email: e.m.vanleeuwen{at}amc.uva.nl.
To obtain insight in human CD4+ T cell differentiation and selection in vivo we longitudinally studied cytomegalovirus (CMV)-specific CD4+ T cells after primary infection. Early in infection CMV-specific CD4+ T cells have the appearance of IFN -producing TH1 type cells, whereas during latency a large population of CMV-specific CD4+CD28- T cells emerges with immediate cytotoxic capacity. We here demonstrate that CD4+CD28- T cells could lyse CMV-antigen expressing target cells in a class-II dependent manner. To clarify the clonal relationship between early and late CMV-specific CD4+ T cells we determined their V usage and CDR3 sequences. The TCR diversity in the early CMV-specific CD4+ T cell population was high in contrast to the use of a very restricted set of TCR sequences in latent infection. T-cell clones found in the late CMV-specific CD4+ T cell population could not, or only at low frequency, be retrieved from the early CD4+ T cell population. The observation that dominant CMV-specific CD4+ clones during latency were only poorly represented in the acute phase suggests that after the initial control of the virus strong selection and/or priming of novel clones takes place in persistent infections in man.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. K. L. Cheung, D. J. Gottlieb, B. Plachter, S. Pepperl-Klindworth, S. Avdic, A. L. Cunningham, A. Abendroth, and B. Slobedman
The role of the human cytomegalovirus UL111A gene in down-regulating CD4+ T-cell recognition of latently infected cells: implications for virus elimination during latency
Blood,
November 5, 2009;
114(19):
4128 - 4137.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. B. Sacha, J. P. Giraldo-Vela, M. B. Buechler, M. A. Martins, N. J. Maness, C. Chung, L. T. Wallace, E. J. Leon, T. C. Friedrich, N. A. Wilson, et al.
Gag- and Nef-specific CD4+ T cells recognize and inhibit SIV replication in infected macrophages early after infection
PNAS,
June 16, 2009;
106(24):
9791 - 9796.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Walton, P. Wyrsch, M. W. Munks, A. Zimmermann, H. Hengel, A. B. Hill, and A. Oxenius
The Dynamics of Mouse Cytomegalovirus-Specific CD4 T Cell Responses during Acute and Latent Infection
J. Immunol.,
July 15, 2008;
181(2):
1128 - 1134.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Jenkins, W. Garcia, M. J. Godwin, J. V. Spencer, J. L. Stern, A. Abendroth, and B. Slobedman
Immunomodulatory Properties of a Viral Homolog of Human Interleukin-10 Expressed by Human Cytomegalovirus during the Latent Phase of Infection
J. Virol.,
April 1, 2008;
82(7):
3736 - 3750.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. J. M. ten Berge and R. A. W. van Lier
Attack of the CD4 clones
Blood,
February 15, 2008;
111(4):
1750 - 1751.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Crompton, N. Khan, R. Khanna, L. Nayak, and P. A. H. Moss
CD4+ T cells specific for glycoprotein B from cytomegalovirus exhibit extreme conservation of T-cell receptor usage between different individuals
Blood,
February 15, 2008;
111(4):
2053 - 2061.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Price, A. D. Bitmansour, J. B. Edgar, J. M. Walker, M. K. Axthelm, D. C. Douek, and L. J. Picker
Induction and Evolution of Cytomegalovirus-Specific CD4+ T Cell Clonotypes in Rhesus Macaques
J. Immunol.,
January 1, 2008;
180(1):
269 - 280.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Vescovini, C. Biasini, F. F. Fagnoni, A. R. Telera, L. Zanlari, M. Pedrazzoni, L. Bucci, D. Monti, M. C. Medici, C. Chezzi, et al.
Massive Load of Functional Effector CD4+ and CD8+ T Cells against Cytomegalovirus in Very Old Subjects
J. Immunol.,
September 15, 2007;
179(6):
4283 - 4291.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kannanganat, C. Ibegbu, L. Chennareddi, H. L. Robinson, and R. R. Amara
Multiple-Cytokine-Producing Antiviral CD4 T Cells Are Functionally Superior to Single-Cytokine-Producing Cells
J. Virol.,
August 15, 2007;
81(16):
8468 - 8476.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Casazza, M. R. Betts, D. A. Price, M. L. Precopio, L. E. Ruff, J. M. Brenchley, B. J. Hill, M. Roederer, D. C. Douek, and R. A. Koup
Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation
J. Exp. Med.,
December 25, 2006;
203(13):
2865 - 2877.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|